Potential of carrageenans to protect drugs from polymorphic transformation

Author： Schmidt A.G.   Wartewig S.   Picker K.M.  

Publisher： Elsevier

ISSN： 0939-6411

Source： European Journal of Pharmaceutics and Biopharmaceutics, Vol.56, Iss.1, 2003-07, pp. : 101-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs from the Sea: Conopeptides as Potential Therapeutics

By  

Current Medicinal Chemistry, Vol. 11, Iss. 13, 2004-07 ,pp. : 1715-1723

Bentham Science Publishers

Access to resources Recommend Favorite

Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors

By Gupta V.K.   Hariharan M.   Wheatley T.A.   Price J.C.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 51, Iss. 3, 2001-05 ,pp. : 241-248

Elsevier

Access to resources Recommend Favorite

Kinetics of the Solution-Mediated Polymorphic Transformation of Organic Compounds

By  

Current Pharmaceutical Design, Vol. 24, Iss. 21, 2018-06 ,pp. : 2383-2393

Bentham Science Publishers

Access to resources Recommend Favorite

Polymorphic OCT1: a valid biomarker, but for which drugs?

By Brockmöller Jürgen   Tzvetkov Mladen V  

Pharmacogenomics, Vol. 14, Iss. 16, 2013-12 ,pp. : 1933-1936

Future Medicine

Access to resources Recommend Favorite

Polyisoprenylated Benzophenones from Clusiaceae: Potential Drugs and Lead Compounds

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 16, 2009-11 ,pp. : 1560-1580

Bentham Science Publishers

Access to resources Recommend Favorite